4d Molecular Therapeutics Stock Market Value
| FDMT Stock | USD 9.25 0.15 1.65% |
| Symbol | FDMT |
Is there potential for Biotechnology market expansion? Will FDMT introduce new products? Factors like these will boost the valuation of 4D Molecular. Market participants price FDMT higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about 4D Molecular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.75) | Revenue Per Share | Quarterly Revenue Growth 29 | Return On Assets | Return On Equity |
4D Molecular Therapeutics's market price often diverges from its book value, the accounting figure shown on FDMT's balance sheet. Smart investors calculate 4D Molecular's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since 4D Molecular's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between 4D Molecular's value and its price as these two are different measures arrived at by different means. Investors typically determine if 4D Molecular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 4D Molecular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
4D Molecular 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 4D Molecular's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 4D Molecular.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in 4D Molecular on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding 4D Molecular Therapeutics or generate 0.0% return on investment in 4D Molecular over 90 days. 4D Molecular is related to or competes with Kalvista Pharmaceuticals, Omeros, Bicycle Therapeutics, Gossamer Bio, Lexicon Pharmaceuticals, ADC Therapeutics, and Neumora Therapeutics. 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-asso... More
4D Molecular Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 4D Molecular's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess 4D Molecular Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 27.09 | |||
| Value At Risk | (9.69) | |||
| Potential Upside | 7.04 |
4D Molecular Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 4D Molecular's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 4D Molecular's standard deviation. In reality, there are many statistical measures that can use 4D Molecular historical prices to predict the future 4D Molecular's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | (0.08) |
4D Molecular February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.07) | |||
| Mean Deviation | 3.92 | |||
| Coefficient Of Variation | (5,109) | |||
| Standard Deviation | 5.34 | |||
| Variance | 28.56 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.74) | |||
| Treynor Ratio | (0.08) | |||
| Maximum Drawdown | 27.09 | |||
| Value At Risk | (9.69) | |||
| Potential Upside | 7.04 | |||
| Skewness | (0.97) | |||
| Kurtosis | 2.23 |
4D Molecular Therapeutics Backtested Returns
4D Molecular Therapeutics retains Efficiency (Sharpe Ratio) of -0.0196, which signifies that the company had a -0.0196 % return per unit of price deviation over the last 3 months. 4D Molecular exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 4D Molecular's Information Ratio of (0.04), variance of 28.56, and Market Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 1.48, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, 4D Molecular will likely underperform. At this point, 4D Molecular Therapeutics has a negative expected return of -0.11%. Please make sure to confirm 4D Molecular's information ratio, as well as the relationship between the potential upside and rate of daily change , to decide if 4D Molecular Therapeutics performance from the past will be repeated sooner or later.
Auto-correlation | -0.7 |
Very good reverse predictability
4D Molecular Therapeutics has very good reverse predictability. Overlapping area represents the amount of predictability between 4D Molecular time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of 4D Molecular Therapeutics price movement. The serial correlation of -0.7 indicates that around 70.0% of current 4D Molecular price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.49 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for FDMT Stock Analysis
When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.